MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $67,047,000 | -2.3% | 1,111,880 | -25.5% | 0.08% | -5.0% |
| Q1 2016 | $68,640,000 | +7.2% | 1,492,831 | +12.7% | 0.08% | +9.6% |
| Q4 2015 | $64,059,000 | +1.4% | 1,325,156 | -10.8% | 0.07% | +4.3% |
| Q3 2015 | $63,169,000 | -26.8% | 1,486,339 | +96.6% | 0.07% | -15.7% |
| Q2 2015 | $86,354,000 | -13.9% | 756,156 | -2.7% | 0.08% | -14.4% |
| Q1 2015 | $100,321,000 | +34.2% | 777,269 | +3.5% | 0.10% | +36.6% |
| Q4 2014 | $74,775,000 | +17.3% | 750,682 | +16.4% | 0.07% | +12.7% |
| Q3 2014 | $63,747,000 | +20.4% | 644,748 | -6.2% | 0.06% | +18.9% |
| Q2 2014 | $52,967,000 | +0.8% | 687,166 | -15.8% | 0.05% | -5.4% |
| Q1 2014 | $52,547,000 | +24.3% | 816,322 | +23.2% | 0.06% | +16.7% |
| Q4 2013 | $42,275,000 | +2.7% | 662,420 | -3.5% | 0.05% | -5.9% |
| Q3 2013 | $41,154,000 | +38.8% | 686,588 | +13.9% | 0.05% | +34.2% |
| Q2 2013 | $29,650,000 | – | 602,634 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |